Astrazeneca Pharma India Outperforms Market Amid Broader Decline, Shows Strong Long-Term Growth

Astrazeneca Pharma India has shown remarkable performance today, gaining 8.65% on June 2, 2025. This surge comes as the stock outperformed its sector by 9.13%, reflecting strong momentum in a challenging market environment. Over the past three days, Astrazeneca Pharma has consistently gained, accumulating a total return of 10.39%.
The stock opened with a notable gain of 6.01% and reached an intraday high of Rs 8,680, marking an increase of 8.89%. Astrazeneca Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust upward trend.

In contrast, the broader market has faced challenges, with the Sensex declining by 0.74% today and experiencing a three-week consecutive fall. Despite this, Astrazeneca Pharma's performance stands out, with a year-to-date increase of 18.26% and an impressive 40.76% rise over the past year. The stock has also demonstrated significant long-term growth, with a remarkable 819.73% increase over the last decade, showcasing its strong position in the pharmaceuticals and biotechnology industry.